NUTRITION ADVANCING LIFE
LIVE

Serial Number

79256120

Owner

Vernx Biotechnology Pty Ltd

Attorney

Michelle P. Ciotola

Filing Date

Feb 26, 2019

Add to watchlist:

No watchlists yet
View on USPTO

NUTRITION ADVANCING LIFE Trademark

Serial Number: 79256120 • Registration: 5969827

NUTRITION ADVANCING LIFE is a trademark filed by Vernx Biotechnology Pty Ltd on February 26, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Vernx Biotechnology Pty Ltd (3 trademarks)

10 Norman St

Entity Type: 82

Vernx Pty Ltd (5 trademarks)

10 Norman St

Entity Type: 82

Trademark Details

Filing Date

February 26, 2019

Registration Date

January 28, 2020

Published for Opposition

November 12, 2019

Cancellation Date

August 14, 2026

Goods & Services

Scientific and technological services and research and design relating thereto, namely pharmaceutical research and new product development, research and design thereto; scientific and technological research services in the pharmaceutical, biotechnology, biochemistry and chemistry fields; scientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceutical products; biotechnology research; biochemistry research and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; services for assessing the efficacy and safety of pharmaceuticals, namely pharmaceutical product evaluation and testing and inspection of pharmaceuticals; preparation of scientific reports relating to scientific research; analytical laboratory services, namely chemical and medical laboratories; laboratory research and analysis in the pharmaceutical, biotechnology, biochemistry and chemistry fields; development of products; development of new products; advisory services relating to scientific research; scientific consultancy and information services relating to the aforementioned services

Pharmaceutical preparations and substances for the treatment, prevention and management of immune disorders and inflammatory diseases of the gastrointestinal system, gastro-intestinal diseases and intestinal diseases in babies and infants; gastro-intestinal treatment preparations; medicines for human use for the treatment, prevention and management of immune disorders and inflammatory diseases of the gastrointestinal system, gastro-intestinal diseases and intestinal diseases in babies and infants; medicines for intestinal disorders; pharmaceutical products, namely pills, capsules, tablets, caplets, liquid drops, sachets and beverages for the treatment, prevention and management of immune disorders and inflammatory diseases of the gastrointestinal system, gastro-intestinal diseases and intestinal diseases in babies and infants; chemical preparations for pharmaceutical purposes for the treatment, prevention and management of immune disorders and inflammatory diseases of the gastrointestinal system, gastro-intestinal diseases and intestinal diseases in babies and infants; chemicals for pharmaceutical use for the treatment, prevention and management of immune disorders and inflammatory diseases of the gastrointestinal system, gastro-intestinal diseases and intestinal diseases in babies and infants; diagnostic preparations for medical purposes; pharmaceutical preparations, herbal supplements and veterinary preparations all for the prevention, treatment and management of immune disorders and inflammatory diseases of the gastrointestinal system

Filing History

CANCELLED SECTION 71
Aug 14, 2026 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 28, 2025 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 24, 2022 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
May 29, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 7, 2020 FICS
FINAL DISPOSITION PROCESSED
May 7, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 28, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 28, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 12, 2019 NPUB
PUBLISHED FOR OPPOSITION
Nov 12, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Nov 9, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 23, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 23, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 23, 2019 NONP
ASSIGNED TO LIE
Oct 10, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 7, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 27, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 27, 2019 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Jun 27, 2019 NREP
REFUSAL PROCESSED BY IB
Jun 22, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 2, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jun 1, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 14, 2019 RFCR
NON-FINAL ACTION WRITTEN
May 13, 2019 CNRT
ASSIGNED TO EXAMINER
May 7, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 16, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 12, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 11, 2019 REPR